Picture of Nidhogg Resources Holding AB (publ) logo

NIDHOG Nidhogg Resources Holding AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
Basic MaterialsHighly SpeculativeMicro CapSucker Stock

Brief: Eurocine Vaccines Has Selected Biovian As Contract Developer For The Chlamydia Vaccine Candidate

Dec 30 (Reuters) - Eurocine Vaccines AB  EUCI.TE :
    * EUROCINE VACCINES HAS SELECTED BIOVIAN AS CONTRACT
DEVELOPER FOR
THE CHLAMYDIA VACCINE CANDIDATE
    * COLLABORATION SIGNED TODAY WITH BIOVIAN COVERS ACTIVITIES
INITIALLY LASTING UNTIL NOVEMBER 2021
    * AGREEMENT SIGNED TODAY INCLUDES ACTIVITIES AT A TOTAL COST
OF
APPR. SEK 9.5 MILLION (EUR 0.94 MILLION)

Source text for Eikon:  ID:nWkr1bNBlk 
Further company coverage:  EUCI.TE 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Nidhogg Resources Holding AB (publ)

See all news